Highnoon proudly participated in the 7th Pakistan Pharma Export Summit & Awards (PESA 2024), hosted by the Pakistan Pharmaceutical Manufacturers Association (PPMA), celebrating the achievements of Pakistani pharmaceutical companies in the global market. As a leading pharmaceutical company, Highnoon joined industry professionals and government officials at this prestigious event.
In recognition of its contributions to pharmaceutical exports, Highnoon was honored with the Pharma Export Award, presented by Yousuf Raza Gillani, Chairman of the Senate of Pakistan. This marks the second year in a row that Highnoon has received this award, highlighting its ongoing commitment to excellence in exports.
Mr. Shahnawaz Baig, Group Director of Commercial Excellence, accepted the award and engaged in discussions about export strategies, growth potential, and industry challenges. The panel also emphasized the importance of innovation and digital transformation in the pharmaceutical sector. Highnoon remains committed to leveraging these advancements to improve patient outcomes, positioning itself at the forefront of industry progress. This recognition reinforces Highnoon’s mission to enrich lives globally, underscoring its dedication to excellence in pharmaceuticals.
